EVOS™ M5000 Imaging System

Closed Pre-Solicitation Posted

Solicitation number
75N98026Q01178
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Bethesda, Maryland 20892, United States
Points of contact

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institutes of Health intends to award a firm-fixed-price purchase order to Thermo Fisher Scientific for one EVOS M5000 Imaging System under a sole-source justification (FAR 6.302-1), with a response deadline of September 18, 2026. The Laboratory of Cancer Biology and Genetics requires an integrated imaging platform to support pancreatic cancer research, including brightfield and fluorescence imaging, immunofluorescence analysis, transwell migration assays, live-cell imaging, and bacterial-host interaction studies.

The system must deliver immediate, standardized imaging capabilities on-site to support time-sensitive live-cell and fluorescent specimen analysis and reduce reliance on shared microscopy facilities. The Government requires the EVOS M5000 equipped with a 3.2-megapixel scientific-grade monochrome camera and 18.5-inch articulated LCD monitor, paired with an EVOS Objective Starter Kit containing 4X, 10X, and 20X fluorite long-working-distance objectives for brightfield, phase contrast, and fluorescence imaging.

NIH determined that the EVOS M5000 is the only commercially available system meeting the complete combination of functional, technical, operational, and workflow requirements as an integrated platform without requiring additional third-party hardware, software, or custom configuration. Other evaluated systems provide individual comparable components but require supplementary hardware, separate computers, third-party software, or extensive configuration to achieve equivalent functionality.

This notice is not a request for competitive quotations. Interested parties believing they can meet the Government's requirements may submit a capability statement.

Notice text

The National Institutes of Health (NIH) intends to award a Firm-Fixed-Price Purchase Order to Thermo Fisher Scientific for an EVOS™ M5000 Imaging System.

The Government intends to solicit from a single source in accordance with FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.

The Laboratory of Cancer Biology and Genetics (LCBG) requires an integrated imaging system to support ongoing NIH-funded research involving pancreatic cancer, including brightfield and fluorescence imaging, immunofluorescence analysis, transwell migration assays, live-cell imaging, bacterial-host interaction studies, and quantitative analysis of tissue specimens.

The required system must provide immediate, standardized brightfield and fluorescence imaging capabilities within the laboratory to support time-sensitive live-cell and fluorescent specimen imaging and reduce dependence on shared microscopy facilities.

The Government requires the following:

  • One (1) EVOS™ M5000 Imaging System, equipped with a 3.2-megapixel scientific-grade monochrome camera and 18.5-inch articulated LCD monitor.
  • One (1) EVOS™ Objective Starter Kit, containing 4X, 10X, and 20X fluorite long-working-distance objectives for brightfield, phase contrast, and fluorescence imaging.

The EVOS™ M5000 was identified as the only commercially available system that meets the Government's complete combination of functional, technical, operational, and workflow requirements as an integrated platform without requiring additional third-party hardware, software, or custom configuration. Other systems evaluated may provide individual comparable components but require additional hardware, separate computers, third-party software, or extensive configuration to provide equivalent functionality.

This notice is not a request for competitive quotations. However, interested parties that believe they can meet the Government's requirements may submit a capability statement demonstrating their ability to provide a system meeting all specified technical and operational requirements.

The Government will consider all timely capability statements received and determine whether the acquisition should proceed as a sole-source procurement or be competed.

The Government anticipates making an award approximately five (5) calendar days after the closing date of this notice, unless the Government determines that another responsible source is capable of meeting the requirement.

Capability statements shall be submitted electronically to haunp@mail.nih.gov no later than 9:00 a.m. EDT on September 18, 2026.

Please reference Notice No. 75N98026Q01178 in the subject line of the response.

Similar open opportunities

Opportunity Agency Set-aside Responses due
Intent to Sole Source - Medical/Scientific Instruments for the Department of Transfusion Medicine, NIH Clinical Center Bethesda, Maryland 20892, United States · NAICS 334516 National Institutes of Health No set-aside
Service agreement for the Nikon AXR-NSPARC confocal Bethesda, Maryland 20892, United States Office of Logisitics and Acquisition Operations No set-aside
Service Maintenance for Leica Stellaris 8 SN 8300000509 Bethesda, Maryland 20892, United States · NAICS 811210 Office of Logisitics and Acquisition Operations No set-aside
Service Maintenance for MoFlo Astrio AW10012 Bethesda, Maryland 20892, United States · NAICS 811210 Office of Logisitics and Acquisition Operations No set-aside
Intent to Sole Source - BD FACSCanto II instrument Bethesda, Maryland 20892, United States · NAICS 334516 National Institutes of Health No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity